Boston Scientific won't comment on whether rival device maker Stryker made a takeover bid, CNBC reports.
Here's what you should know:
1. Stryker allegedly approached Boston Scientific with a deal to acquire the device maker. If a deal comes to fruition, the combined company would be worth approximately $110 billion.
2. Stryker also declined to comment on the potential takeover.
3. CNBC speculates a merger would better position both companies in the device sector, specifically with regard to competing against Medtronic.
4. Stock analysts are split on the potential acquisition. BMO Capital Markets analyst Joanne Wuensch said the acquisition would be "one of the final major puzzle piece acquisitions." While, J.P. Morgan analyst Robbie Marcus said bigger isn't necessarily better.